PREECLAMPSIA (PE)

This study is testing whether giving progesterone (17 OHPC) to pregnant women with preeclampsia before 34 weeks can improve outcomes for them and their babies. The trial will enroll 60 women at the University of Mississippi Medical Center. Researchers will monitor blood pressure …

This study tests whether a daily dose of pravastatin, a common heart medication, can safely prolong pregnancy in women diagnosed with severe early-onset preeclampsia or fetal growth restriction. The trial will include 154 pregnant women between 24 and 30 weeks of gestation, rando…

This study aims to improve early detection of preeclampsia, a dangerous pregnancy condition. Researchers will collect blood samples from over 6,500 pregnant women between 11-14 weeks of pregnancy and compare the results with pregnancy outcomes. The goal is to see how well a new b…

This study is testing a new blood test called the MaiRa Preeclampsia Test to see if it can accurately predict preeclampsia early in pregnancy. Preeclampsia is a serious condition that can harm both mother and baby. The test looks at genetic material in the mother's blood to ident…

This study is testing whether a simple screening test in early pregnancy (around 11-14 weeks) can predict and help prevent preeclampsia, a dangerous condition involving high blood pressure. The trial will involve 14,500 pregnant women and aims to reduce severe complications like …

This study aims to see if a new screening program during the first trimester can better identify pregnant women at risk for preeclampsia—a condition causing high blood pressure that can harm both mother and baby. Up to 80,000 women in Denmark will take part. Those found to be hig…

This study follows 1,260 women 3 to 6 years after their first pregnancy to see how pregnancy complications like preeclampsia affect heart health. Researchers will measure blood pressure, heart function, and artery health, and consider lifestyle and environment. The goal is to cre…

This study will test a new way to screen pregnant women during their first trimester (weeks 11-13) to predict serious problems like preeclampsia, poor fetal growth, and birth defects. About 2000 women over 18 will take part. The goal is to create a standard screening method that …

This study looks at how a pregnant person's metabolism—specifically insulin resistance and fat burning—may be linked to placenta health and pregnancy complications like preeclampsia and gestational diabetes. Researchers will follow 50 pregnant women at high or moderate risk for p…

This study is following 250 pregnant women diagnosed with preeclampsia, a serious condition involving high blood pressure and organ problems. Researchers will collect health data and samples from mothers and babies during pregnancy, at birth, and a few months after. The goal is t…

This study looks at how pregnant women at risk for preeclampsia process aspirin and how that relates to signs of metabolic problems. Researchers will measure aspirin breakdown products and other health markers in blood and urine. The goal is to better understand why some women st…